Select Medical
SEM
Market cap $1.6B

12.93 USD

-0.25

1.90%

Updated Aug 26, 11:22 AM EDT

1 day

-1.90%

5 days

-0.39%

1 month

-8.62%

3 months

-13.28%

6 months

-30.11%

Year to date

-31.19%

1 year

-32.87%

5 years

23.73%

10 years

92.99%

About: Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.

Employees: 44,100

Healthcare Medical Care Facilities

0

Funds holding %

of 7,431 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

28% more repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 81

4.88% less ownership

Funds ownership: 82.74% [Q1] → 77.85% (-4.88%) [Q2]

5% less funds holding

Funds holding: 273 [Q1] → 259 (-14) [Q2]

15% less capital invested

Capital invested by funds: $1.78B [Q1] → $1.52B (-$263M) [Q2]

17% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 46

See Fund Rankings

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target

$14

8%

upside

Avg. target

$14

8%

upside

High target

$14

8%

upside

1 analyst rating

0 positive

0%

1 neutral

100%

0 negative

0%

UBS

A.J. Rice

8%upside

$14

Neutral

Maintained

4 Aug 2025

See Analyst Rankings

Financial journalist opinion

Based on 7 articles about SEM published over the past 30 days

The Motley Fool

Select Medical (SEM) Q2 2025 Earnings Transcript

Image source: The Motley Fool.

Select Medical (SEM) Q2 2025 Earnings Transcript

Zacks Investment Research

Select Medical Shares Down 20% Despite Q2 Earnings Beat

SEM beats Q2 EPS estimates on strong Rehab admissions and higher revenue per patient day. Yet, shares drop 20.4% post-earnings.

Select Medical Shares Down 20% Despite Q2 Earnings Beat

Zacks Investment Research

Should Value Investors Buy Select Medical (SEM) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Select Medical (SEM) Stock?

Zacks Investment Research

Here's Why Select Medical (SEM) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Select Medical (SEM) is a Strong Value Stock

Select Medical Holdings Corporation (SEM) Q2 2025 Earnings Call Transcript

Select Medical Holdings Corporation (NYSE:SEM ) Q2 2025 Earnings Conference Call August 1, 2025 9:00 AM ET Company Participants Michael F. Malatesta - Executive VP & CFO Robert A.

Select Medical Holdings Corporation (SEM) Q2 2025 Earnings Call Transcript

Zacks Investment Research

Select Medical (SEM) Surpasses Q2 Earnings and Revenue Estimates

Select Medical (SEM) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.6 per share a year ago.

Select Medical (SEM) Surpasses Q2 Earnings and Revenue Estimates

Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2025 and Cash Dividend

MECHANICSBURG, Pa. , July 31, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its second quarter ended June 30, 2025, and the declaration of a cash dividend.

Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2025 and Cash Dividend

Select Medical: Despite A Change In The Regulatory Environment, This Prospect Is Worth Considering

Select Medical Holdings remains a soft 'buy' due to attractive valuation, organic growth, and solid top-line performance despite recent share price decline. Legislative changes pose risks, particularly from reduced Medicaid coverage, but only a small portion of revenue is exposed to this headwind. Recent results show revenue growth and improving profitability from continuing operations, though some metrics like EBITDA and adjusted cash flow have softened.

Select Medical: Despite A Change In The Regulatory Environment, This Prospect Is Worth Considering

Zacks Investment Research

Why Select Medical (SEM) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Select Medical (SEM) is a Top Value Stock for the Long-Term

Zacks Investment Research

Select Medical Expands Presence in Tennessee With Ballad Health Deal

SEM partners with Ballad Health to relocate and expand its Tri-Cities critical illness recovery hospital, boosting care access in Tennessee by being able to treat more patients grappling with serious illnesses.

Select Medical Expands Presence in Tennessee With Ballad Health Deal

See News Rankings

Charts implemented using Lightweight Charts™